Jacobs Levy Equity Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-139,806
| Closed | -$1.23M | – | 965 |
|
|
2025
Q3 | $1.23M | Sell |
139,806
-69,167
| -33% | -$538K | ﹤0.01% | 676 |
|
|
2025
Q2 | $1.33M | Buy |
208,973
+12,589
| +6% | +$72K | 0.01% | 700 |
|
|
2025
Q1 | $954K | Buy |
196,384
+11,067
| +6% | +$91.6K | ﹤0.01% | 816 |
|
|
2024
Q4 | $1.77M | Hold |
185,317
| – | – | 0.01% | 617 |
|
|
2024
Q3 | $1.55M | Buy |
+185,317
| New | +$1.68M | 0.01% | 650 |
|
|
2024
Q1 | – | Sell |
-1,043,284
| Closed | -$2.5M | – | 966 |
|
|
2023
Q4 | $2.5M | Sell |
1,043,284
-202,736
| -16% | -$476K | 0.01% | 566 |
|
|
2023
Q3 | $4.24M | Buy |
1,246,020
+11,573
| +0.9% | +$64.2K | 0.03% | 407 |
|
|
2023
Q2 | $9.07M | Sell |
1,234,447
-9,335
| -0.8% | -$86.6K | 0.05% | 293 |
|
|
2023
Q1 | $12.9M | Sell |
1,243,782
-9,260
| -0.7% | -$112K | 0.08% | 248 |
|
|
2022
Q4 | $14.8M | Buy |
1,253,042
+284,536
| +29% | +$4.4M | 0.1% | 226 |
|
|
2022
Q3 | $20.3M | Sell |
968,506
-117,368
| -11% | -$3.27M | 0.16% | 162 |
|
|
2022
Q2 | $33.7M | Buy |
1,085,874
+582,586
| +116% | +$19.9M | 0.26% | 106 |
|
|
2022
Q1 | $20.7M | Buy |
+503,288
| New | +$22.2M | 0.14% | 171 |
|
|
2018
Q4 | – | Sell |
-3,880
| Closed | -$255K | – | 1000 |
|
|
2018
Q3 | $255K | Sell |
3,880
-1,800
| -32% | -$105K | ﹤0.01% | 896 |
|
|
2018
Q2 | $287K | Sell |
5,680
-13,000
| -70% | -$677K | ﹤0.01% | 893 |
|
|
2018
Q1 | $984K | Sell |
18,680
-168,553
| -90% | -$8.4M | 0.02% | 639 |
|
|
2017
Q4 | $8.7M | Buy |
187,233
+22,830
| +14% | +$961K | 0.15% | 189 |
|
|
2017
Q3 | $6.65M | Buy |
164,403
+13,530
| +9% | +$490K | 0.13% | 219 |
|
|
2017
Q2 | $5.12M | Buy |
150,873
+160
| +0.1% | +$4.94K | 0.11% | 232 |
|
|
2017
Q1 | $4.38M | Buy |
150,713
+45,160
| +43% | +$1.37M | 0.09% | 275 |
|
|
2016
Q4 | $3.47M | Buy |
105,553
+37,540
| +55% | +$1.13M | 0.07% | 311 |
|
|
2016
Q3 | $2.14M | Sell |
68,013
-27,902
| -29% | -$811K | 0.04% | 404 |
|
|
2016
Q2 | $2.7M | Buy |
95,915
+37,782
| +65% | +$1.48M | 0.06% | 367 |
|
|
2016
Q1 | $2.11M | Hold |
58,133
| – | – | 0.04% | 392 |
|
|
2015
Q4 | $2.33M | Sell |
58,133
-770
| -1% | -$26.8K | 0.05% | 317 |
|
|
2015
Q3 | $1.68M | Sell |
58,903
-47,170
| -44% | -$1.55M | 0.03% | 394 |
|
|
2015
Q2 | $3.5M | Sell |
106,073
-2,470
| -2% | -$76.6K | 0.07% | 275 |
|
|
2015
Q1 | $3.12M | Sell |
108,543
-10,800
| -9% | -$310K | 0.05% | 300 |
|
|
2014
Q4 | $3.25M | Sell |
119,343
-22,460
| -16% | -$535K | 0.06% | 305 |
|
|
2014
Q3 | $3.02M | Sell |
141,803
-19,440
| -12% | -$445K | 0.05% | 317 |
|
|
2014
Q2 | $3.62M | Sell |
161,243
-21,000
| -12% | -$489K | 0.06% | 318 |
|
|
2014
Q1 | $4.61M | Sell |
182,243
-7,510
| -4% | -$190K | 0.08% | 272 |
|
|
2013
Q4 | $4.36M | Sell |
189,753
-2,600
| -1% | -$54.2K | 0.07% | 312 |
|
|
2013
Q3 | $3.66M | Sell |
192,353
-55,950
| -23% | -$999K | 0.06% | 326 |
|
|
2013
Q2 | $3.58M | Buy |
+248,303
| New | +$3.6M | 0.06% | 324 |
|
Other funds holding EBS
OHA
PCM
